GR74627B - - Google Patents

Info

Publication number
GR74627B
GR74627B GR65799A GR810165799A GR74627B GR 74627 B GR74627 B GR 74627B GR 65799 A GR65799 A GR 65799A GR 810165799 A GR810165799 A GR 810165799A GR 74627 B GR74627 B GR 74627B
Authority
GR
Greece
Application number
GR65799A
Inventor
Janos Kollonitsch
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of GR74627B publication Critical patent/GR74627B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR65799A 1980-08-18 1981-08-14 GR74627B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17935880A 1980-08-18 1980-08-18

Publications (1)

Publication Number Publication Date
GR74627B true GR74627B (el) 1984-06-29

Family

ID=22656255

Family Applications (1)

Application Number Title Priority Date Filing Date
GR65799A GR74627B (el) 1980-08-18 1981-08-14

Country Status (8)

Country Link
EP (1) EP0046290B1 (el)
JP (1) JPS5759812A (el)
AU (1) AU7398381A (el)
DD (1) DD200404A5 (el)
DE (1) DE3168036D1 (el)
FI (1) FI812469L (el)
GR (1) GR74627B (el)
PT (1) PT73517B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)
US5030645A (en) * 1990-10-15 1991-07-09 Merck & Co., Inc. Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof
FR2822709B1 (fr) * 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
FR2896156A1 (fr) * 2006-01-17 2007-07-20 Gaetan Terrasse Nouvelle utilisation de la tritoqualine en association avec des substances medicamenteuses antagonistes du recepteur h2 a l'histamine,pour le traitement des maladies inflammatoires digestives
WO2008100539A1 (en) * 2007-02-12 2008-08-21 Michalis Nicolaou Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, lra drugs, anti-h1 and/or anti-h2 drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000302A (en) * 1972-04-20 1976-12-28 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US4215221A (en) * 1977-06-01 1980-07-29 Merck & Co., Inc. Fluorination process

Also Published As

Publication number Publication date
JPH0154326B2 (el) 1989-11-17
EP0046290B1 (en) 1985-01-02
DD200404A5 (de) 1983-05-04
PT73517B (en) 1983-07-06
EP0046290A1 (en) 1982-02-24
DE3168036D1 (en) 1985-02-14
FI812469L (fi) 1982-02-19
PT73517A (en) 1981-09-01
JPS5759812A (en) 1982-04-10
AU7398381A (en) 1982-02-25

Similar Documents

Publication Publication Date Title
FR2475849B1 (el)
FR2472931B1 (el)
FR2475710B1 (el)
FR2482075B1 (el)
FR2473847B1 (el)
FR2473816B1 (el)
DE3050591T1 (el)
FR2474076B1 (el)
FR2474855B1 (el)
FR2473351B1 (el)
FR2473482B1 (el)
FR2473777B3 (el)
FR2473538B1 (el)
FR2476127B1 (el)
FR2473886B1 (el)
DE3148629T1 (el)
FR2457100B1 (el)
FR2473982B1 (el)
FR2475941B1 (el)
FR2473383B1 (el)
FR2474087B1 (el)
FR2473938B1 (el)
FR2475793B3 (el)
GR74627B (el)
FR2473338B1 (el)